INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Accounts Payable, Related Parties
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Accounts Payable, Related Parties of -$13.32 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-08-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2023-08-23
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for the quarter ending 2022-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for the quarter ending 2022-03-31 was -$9.54K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for the quarter ending 2021-12-31 was -$59.27K, a 157.75% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for the quarter ending 2021-09-30 was $55.48K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for fiscal 2022 was -$13.32K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for fiscal 2021 was -$1.76M, a 163.62% decline from fiscal 2020.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, related parties for fiscal 2020 was $2.76M.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$9.54K derived: sum of 2 quarters · filed 2023-08-23 | -$68.81K derived: sum of 3 quarters · filed 2023-08-23 | -$13.32K 10-K · filed 2023-08-23 |
| 2022-03-31 | -$9.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$68.81K derived: sum of 2 quarters · filed 2023-05-11 | -$13.32K 10-Q · filed 2023-05-11 | -$37.23K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$59.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$3.79K 10-Q · filed 2023-02-14 | -$27.70K derived: sum of 3 quarters · filed 2023-02-14 | -$422.08K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $55.48K 10-Q · filed 2022-11-14 | $31.57K derived: sum of 2 quarters · filed 2022-11-14 | -$362.81K derived: sum of 3 quarters · filed 2022-11-14 | -$260.17K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$23.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | -$418.30K derived: sum of 2 quarters · filed 2022-09-22 | -$315.66K derived: sum of 3 quarters · filed 2022-09-22 | -$1.76M 10-K · filed 2022-09-22 |
| 2021-03-31 | -$394.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$291.75K derived: sum of 2 quarters · filed 2022-05-16 | -$1.73M 10-Q · filed 2022-05-16 | -$1.20M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $102.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | -$1.34M 10-Q · filed 2022-02-11 | -$801.73K derived: sum of 3 quarters · filed 2022-02-11 | -$1.04M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | -$1.44M 10-Q · filed 2021-11-12 | -$904.37K derived: sum of 2 quarters · filed 2021-11-12 | -$1.14M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-30 | $535.94K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $301.78K derived: sum of 2 quarters · filed 2021-09-16 | $2.76M 10-K · filed 2021-09-16 | |
| 2020-03-31 | -$234.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $2.22M 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | $2.46M 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |